OneSource Specialty Pharma Schedules Earnings Call on May 13 to Discuss Q4FY26 Audited Financial Results

OneSource Specialty Pharma Limited has announced the scheduling of an earnings call with analysts and investors on Wednesday, May 13, 2026, at 15:00 hrs IST. The call is intended to discuss the company's audited financial results for the quarter and financial year ended March 31, 2026. The announcement was communicated to stock exchanges on May 07, 2026, in compliance with Regulation 30.

Senior Management to Lead Investor Interaction

The earnings call will feature participation from key members of the company's senior leadership team. The following speakers are scheduled to represent the company:

Arun Kumar — Founder & Non-Executive Chairperson
Neeraj Sharma — CEO & MD
Anurag Bhagania — CFO

Conference Call Access Details

Investors and analysts can participate in the earnings call using the dial-in details provided below. An early registration option via DiamondPass is also available for participants who wish to join ahead of the scheduled time.

Parameter:	Details
Date:	Wednesday, May 13, 2026
Time:	03:00 PM IST
Universal Access (Line 1):	+91 22 6280 1372
Universal Access (Line 2):	+91 22 7115 8193
DiamondPass Registration:	Available via Chorus Call portal

Regulatory Compliance

The disclosure was made by Trisha A, Company Secretary and Compliance Officer (Membership Number: A47635), on behalf of OneSource Specialty Pharma Limited. The communication was addressed to both BSE Limited and the National Stock Exchange of India Ltd, fulfilling the company's obligations under the applicable regulatory framework. The earnings call represents an opportunity for the investment community to engage directly with the company's senior management regarding its full-year and quarterly performance.

1 Day	5 Days	1 Month	6 Months	1 Year	5 Years
+1.06%	+5.59%	+33.34%	+3.24%	+12.35%	+7.32%

OneSource Specialty Pharma Limited has notified the stock exchanges of an upcoming Board of Directors meeting scheduled for Wednesday, May 13, 2026. The intimation was filed on May 07, 2026, in accordance with Regulation 29 of the SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015.

Board Meeting Details

The board meeting has been convened to consider and approve the audited financial results of the company for the quarter and year ended March 31, 2026. The results will be reviewed on both a standalone and consolidated basis, along with other matters as may be taken up during the meeting.

Key details of the scheduled board meeting are summarised below:

Parameter:	Details
Meeting Date:	Wednesday, May 13, 2026
Purpose:	Approval of audited financial results (standalone and consolidated)
Period Under Review:	Quarter and year ended March 31, 2026
Regulatory Basis:	Regulation 29 of SEBI (LODR) Regulations, 2015

Trading Window Closure

In line with the provisions of the Company's Code of Conduct under the SEBI (Prohibition of Insider Trading) Regulations, 2015, the trading window for Designated Persons of the company has been closed effective April 01, 2026, for the quarter ended March 31, 2026. The trading window will reopen 48 hours after the dissemination of the financial results by the company.

The intimation was submitted by Trisha A, Company Secretary and Compliance Officer (Membership Number: A47635), on behalf of OneSource Specialty Pharma Limited.